Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 4/20 | 0.52 |
| ▸ | MEN1 | O00255 | 3/20 | 0.52 |
| ▸ | CCKBR | P32239 | 1/20 | 0.49 |
| ▸ | CASP1 | P29466 | 3/20 | 0.48 |
| ▸ | RAB9A | P51151 | 6/20 | 0.47 |
| ▸ | NPC1 | O15118 | 5/20 | 0.47 |
| ▸ | CASP3 | P42574 | 1/20 | 0.47 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.47 |
| ▸ | DEGS1 | O15121 | 1/20 | 0.47 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.46 |
| ▸ | PLAU | P00749 | 2/20 | 0.44 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.44 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.44 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7659961 | 0.92 | MEN1 (0.52) | KMT2AMEN1CCKBRCASP1RAB9A | |
| SCHEMBL7659998 | 0.90 | MEN1 (0.45) | KMT2AMEN1CCKBRCASP1RAB9A | |
| SCHEMBL7654043 | 0.84 | ALDH1A1 (0.54) | KMT2ACCKBRPLAUHDAC3HDAC1 | |
| SCHEMBL7668106 | 0.83 | CASP1 (0.46) | KMT2AMEN1CCKBRCASP1RAB9A | |
| SCHEMBL7385051 | 0.82 | PTPN1 (0.46) | CCKBRRAB9ANPC1HDAC3HDAC1 | |
| SCHEMBL7666410 | 0.81 | CCKBR (0.42) | KMT2AMEN1CCKBRCASP1RAB9A | |
| SCHEMBL7658785 | 0.79 | ALDH1A1 (0.45) | KMT2AMEN1CCKBRPLAUHDAC3 | |
| SCHEMBL7665000 | 0.77 | ALDH1A1 (0.52) | KMT2AMEN1CCKBRPLAUHDAC3 | |
| SCHEMBL7428036 | 0.76 | CA2 (0.45) | CCKBRRAB9ANPC1HDAC3HDAC1 | |
| SCHEMBL7664997 | 0.74 | PTPN1 (0.51) | KMT2AMEN1CCKBRRAB9ANPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6436925-B1 | BETTER ABLE TO CROSS MEMBRANES; INHIBITORS OF CYSTEINE PROTEASES LIKE CALPAIN I AND II AND CATHEPSIN B AND L, CAN THUS BE USED TO CONTROL DISEASES ASSOCIATED WITH AN ELEVATED ACTIVITY OF CALPAIN ENZYMES OR CATHEPSIN ENZYMES | ABBOTT LABORATORIES | 2002-08-20 | — | — | US | disclosed |